University Hospital Dusseldorf – Germany
About Prof. Dr. Sven Meuth
Univ.-Prof. Dr. med. Dr. rer. nat. Sven Meuth is a senior German Neurologist with over 19 years of experience in multiple sclerosis, neuroimmunology and translational neurology. As Director of the Department of Neurology at University Hospital Düsseldorf and one of Germany's most prolific neuroscientists, he is internationally recognised with 789+ scientific publications and over 23,700 citations.
- 19+ years of experience in Neurology, Neuroimmunology and Translational Neuroscience
- Director — Department of Neurology, University Hospital Düsseldorf, Heinrich Heine University
- PhD in Medicine (MD) and PhD in Natural Sciences (Dr. rer. nat.); Honorary Doctorate (Dr. h.c.)
- Author of 789+ peer-reviewed scientific publications; Google Scholar citations 23,700+
- Recipient of 8+ major German neurology awards including the Heinrich Pette Award (2014)
Qualifications & Credentials
Medical Degrees
- Graduation (Approbation) — German Medical University
- Postgraduate specialisation in Neurology
- PhD in Medicine (Dr. med.)
- PhD in Natural Sciences (Dr. rer. nat.)
- Habilitation (Postdoctoral Lecturing Qualification) — Westphalian Wilhelms University of Münster
- Honorary Doctorate (Dr. h.c.)
Fellowships & Special Training
- Specialist training in Neurology and Translational Neurology
- Sub-specialty training in Neuroimmunology and Multiple Sclerosis
- Specialised expertise in stroke neurology and autoimmune neurological syndromes
Certifications & Accreditations
- German Medical Association — Specialist Registration (Facharzt für Neurologie)
- German Society for Neurology — Member
- European Academy of Neurology — Member
- Multiple Sclerosis Therapy Consensus Group (MSTCG) — Member
Areas of Expertise
Major Conditions Treated
- Multiple Sclerosis (MS)
- Neuromyelitis Optica Spectrum Disorder (NMOSD)
- Autoimmune Limbic Encephalitis
- Anti-GAD65 Autoimmune Neurological Syndromes
- Susac Syndrome
- Stroke (Acute Ischaemic & Haemorrhagic)
- Status Epilepticus & Epilepsy
- Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Myasthenia Gravis
- Neuroinflammation
- Movement Disorders
- Headache & Migraine
- Cognitive Disorders
- Other Neuroimmunological Disorders
Sub-specialties
- Multiple Sclerosis & Neuroimmunology: Comprehensive evaluation and personalised disease-modifying therapy with cutting-edge MS treatments including ofatumumab, anti-CD20 antibodies, cladribine and siponimod — a leading Neurologist specialist in Düsseldorf, Germany for international MS patients.
- Translational Neurology & Clinical Trials: Active research into novel therapeutic targets including TWIK-related potassium channels, AMPA receptor modulation, and remyelination strategies — relevant for international patients researching the best MS specialist in Germany.
- Stroke & Status Epilepticus: Acute and tertiary stroke care including COVID-19-era stroke pathways at the University Hospital Düsseldorf stroke centre.
Advanced Procedures & Treatments
- MS Disease-Modifying Therapy (DMT) — Ocrelizumab, Ofatumumab, Cladribine, Siponimod, Diroximel Fumarate
- Cerebrospinal Fluid (CSF) Analysis & Single-Cell RNA Sequencing
- Acute Stroke Management (Thrombolysis Coordination)
- Status Epilepticus Management
- Plasma Exchange & IVIG for Autoimmune Neurology
- Wearable Sensor / Remote Monitoring Programmes (MS360°)
- Telemedicine & Digital Health Interventions
- Botulinum Toxin Therapy
- EEG, EMG, Nerve Conduction Studies
- Optical Coherence Tomography (OCT) for MS Monitoring
Professional Experience
Current Affiliation
- Director (Klinikdirektor) — Department of Neurology, University Hospital Düsseldorf, Heinrich Heine University, Moorenstrasse 5, 40225 Düsseldorf, Germany (2020–Present)
Past Affiliations
- University Hospital Münster, Germany — Vice-Chair, Department of Neurology (2013–2020)
- Münster University Hospital — Director, Institute of Translational Neurology (2012–Past)
- Westphalian Wilhelms University of Münster — Dean of the Medical Faculty (2019–2020)
- Westphalian Wilhelms University of Münster — Vice Dean for Research and Deputy Dean (2017–2019)
- Department of Neurology, Westphalian Wilhelms University of Münster — Full Professor (2010–2016)
- University Hospital Münster, Germany — Senior Consultant (Past)
- University of Würzburg, Germany — Associate Consultant (Past)
Academic & Research Roles
- Univ.-Prof. of Neurology — Heinrich Heine University, Düsseldorf
- Reviewer for major international neurology and immunology journals (including Nat Med, Nat Commun, Neuron, Cell Res, Nat Rev Drug Discov)
- Member of the Multiple Sclerosis Therapy Consensus Group (MSTCG)
- Active speaker at major international neurology and MS conferences
Key Achievements
- 19+ years of experience in Neurology, Neuroimmunology and Translational Neurology
- Director of Neurology at University Hospital Düsseldorf — one of Germany's leading academic neurology departments
- Author of 789+ peer-reviewed scientific publications
- Google Scholar citations: 23,700+ (one of the most cited German neurologists)
- Recipient of 8+ major German neurology awards including the Heinrich Pette Award
Awards & Recognitions
National & International Awards
- Dissertation Award — Otto-von-Guericke University, Magdeburg, Germany, 2005
- Young-Talent Award — Klaus-Felgenhauer Foundation, 2005
- Helmut Bauer Young-Talent Award for Multiple Sclerosis Research — Göttingen, Germany, 2009
- Oppenheim Young-Talent Award for Multiple Sclerosis Research, 2010
- Sobek Young-Talent Award for Multiple Sclerosis Research, 2010
- Maria Möller Foundation Award (Oncology), 2012
- PRO-SCIENTIA Award — Eckhart-Buddecke Association, 2013
- Heinrich Pette Award — German Society for Neurology, 2014
Professional Memberships
- German Society for Neurology
- European Academy of Neurology
- Multiple Sclerosis Therapy Consensus Group (MSTCG)
- European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
- American Academy of Neurology (AAN)
Research & Publications
Published Papers (Selected)
- Author of 789+ peer-reviewed scientific publications in international high-ranking neurology and immunology journals.
- Bittner S, Meuth SG, et al. "Endothelial TWIK-related potassium channel-1 (TREK1) regulates immune-cell trafficking into the CNS." Nat Med. 2013;19:1161–1165.
- Bierhansl L, Meuth SG, et al. "Thinking outside the box: non-canonical targets in multiple sclerosis." Nat Rev Drug Discov. 2022.
- Ruck T, Meuth SG, et al. "K2P18.1 translates T cell receptor signals into thymic regulatory T cell development." Cell Res. 2022.
- Gross CC, Meuth SG, et al. "CD8+ T cell-mediated endotheliopathy is a targetable mechanism of neuro-inflammation in Susac syndrome." Nat Commun. 2019.
- Kapell H, Meuth SG, et al. "Neuron-oligodendrocyte potassium shuttling at nodes of Ranvier protects against inflammatory demyelination." J Clin Invest. 2023.
Ongoing Research & Clinical Interests
- Multiple sclerosis disease-modifying therapy and treatment switching
- Neuroimmune interactions and CNS immune cell trafficking
- Novel therapeutic targets in MS (TREK1, AMPA receptors, K2P18.1)
- Status epilepticus epidemiology and management
- MS360° hybrid digital-first care framework with wearable sensor monitoring
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (INR) | Estimated Cost (USD) |
|---|---|---|
| Neurology Consultation (Germany) | ₹15,000 – ₹30,000 | $180 – $360 |
| Multiple Sclerosis Diagnostic Workup | ₹2,00,000 – ₹5,00,000 | $2,400 – $6,000 |
| MS Disease-Modifying Therapy (Annual) | ₹15,00,000 – ₹35,00,000 | $18,000 – $42,000 |
| Acute Stroke Treatment Package | ₹6,00,000 – ₹15,00,000 | $7,200 – $18,000 |
| Status Epilepticus / ICU Neurology Care | ₹8,00,000 – ₹20,00,000 | $9,600 – $24,000 |
| Plasma Exchange / IVIG Course | ₹4,00,000 – ₹12,00,000 | $4,800 – $14,400 |
*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.
Frequently Asked Questions
1. What advanced technologies does Prof. Dr. Sven Meuth use in Neurologist treatment?
Prof. Dr. Sven Meuth uses the most advanced neurological technologies including cutting-edge MS disease-modifying therapy (ocrelizumab, ofatumumab, cladribine, siponimod), single-cell RNA sequencing of CSF, optical coherence tomography for MS monitoring, plasma exchange and IVIG for autoimmune neurology, and the MS360° hybrid digital-first care framework with wearable sensor monitoring. Virtual second opinions are also available for international patients.
2. What conditions does Prof. Dr. Sven Meuth specialize in treating?
Prof. Dr. Sven Meuth specialises in multiple sclerosis (MS), neuromyelitis optica spectrum disorder, autoimmune limbic encephalitis, anti-GAD65 syndromes, Susac syndrome, stroke, status epilepticus, CIDP, myasthenia gravis, neuroinflammation, and other neuroimmunological disorders — making him a world-leading Neurologist specialist in Düsseldorf, Germany.
3. How do I book an appointment with Prof. Dr. Sven Meuth?
Appointments with Prof. Dr. Sven Meuth can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.
4. Can international patients receive treatment from Prof. Dr. Sven Meuth?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Prof. Dr. Sven Meuth, including medical visa invitation letters, airport transfers, and local accommodation coordination.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counselling, and pre-travel virtual consultations to review medical records before arrival.
6. Does Prof. Dr. Sven Meuth offer second opinions for Neurologist cases?
Yes. Second opinion consultations can be arranged via Cancer Rounds for patients who wish to review their diagnosis or treatment plan with an expert Neurologist specialist in Düsseldorf, Germany — particularly relevant for multiple sclerosis, autoimmune neurology, and complex neuroimmunological cases.
